
Medical Imaging Market - forecast to 2033 : By MODALITY (X-ray Systems, CT Scanners, MRI Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems, Fluoroscopy Systems, Others), TECHNOLOGY (Digital Imaging, Analog Imaging, Portable Imaging
Description
Medical Imaging Market - forecast to 2033 : By MODALITY (X-ray Systems, CT Scanners, MRI Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems, Fluoroscopy Systems, Others), TECHNOLOGY (Digital Imaging, Analog Imaging, Portable Imaging, Tomosynthesis, Positron Emission Tomography, Single-Photon Emission Computed Tomography), IMAGE TYPE (2D Images, 3D Images, 4D Images), COMPONENT (Imaging Sensors, Detectors, Display Units, Image Processing Units, Contrast Agents), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Gastroenterology, Gynecology, Urology, Pulmonology, Others), END-USER (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research and Academic Institutes, Others), and Region
The Medical Imaging Market is an expansive and dynamic sector dedicated to advancing healthcare diagnostics through sophisticated imaging technologies. This market includes a variety of modalities such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear imaging, each offering distinct advantages in visualizing internal bodily structures for accurate diagnosis, treatment planning, and disease monitoring.
The Medical Imaging Market Market size was USD 40.33 Billion in 2023, and it is anticipated to grow to over 74.21 Billion by 2033, at a CAGR of over 6.3% during the forecast period.
A key driver of the Medical Imaging Market's growth is the rising prevalence of chronic diseases, which underscores the need for early detection and ongoing monitoring. The expanding global aging population and increasing healthcare expenditures further amplify the demand for medical imaging services. Technological advancements, such as the integration of artificial intelligence and machine learning, are enhancing image quality and diagnostic accuracy, thereby fueling market expansion. Additionally, the widespread use of medical imaging systems in hospitals, diagnostic centers, and specialty clinics, along with the ongoing integration of picture archiving and communication systems (PACS) and electronic medical records (EMR), is streamlining workflows and boosting healthcare efficiency. Emerging trends, including portable and handheld devices and advancements in molecular imaging, are extending the reach of diagnostics and opening new avenues for personalized medicine, making medical imaging an essential and evolving component of modern healthcare.
Key Trends:
- Enhanced Focus on AI Integration: The integration of Artificial Intelligence in medical imaging systems is revolutionizing the way diagnoses are conducted, offering predictive analytics and improved accuracy.
- Rise of Portable Imaging Devices: A surge in demand for portable and compact imaging systems is evident, catering to the need for point-of-care diagnostics and telemedicine applications.
- Expansion in Molecular Imaging: Advancements in molecular imaging are providing deeper insights into cellular and molecular functions, paving the way for personalized medicine.
- Increased Adoption of Hybrid Imaging Systems: There is a growing preference for hybrid systems combining different imaging modalities, such as PET/CT and SPECT/CT, to provide comprehensive diagnostic information.
- Growing Importance of 3D Imaging: Three-dimensional imaging technologies are increasingly preferred for their detailed visualization capabilities, aiding in complex surgical planning and procedures.
- Technological Advancements: Continuous innovation in medical imaging technologies, such as AI integration and 3D imaging, enhances diagnostic precision and broadens application scope.
- Aging Population: The growing demographic of elderly individuals worldwide increases the prevalence of chronic diseases, thereby escalating the demand for medical imaging services.
- Healthcare Expenditure: An upsurge in healthcare spending, particularly in developed and emerging economies, correlates with greater investments in medical imaging facilities.
- Regulatory Approvals: Expedited and streamlined regulatory processes for medical devices contribute to the quicker introduction of advanced imaging systems into the market.
- Increase in Non-invasive Procedures: The rising preference for non-invasive diagnostic procedures among patients and healthcare providers is bolstering the adoption of medical imaging modalities.
- Regulatory and Reimbursement Hurdles: Stricter regulations and complex reimbursement scenarios pose significant challenges, slowing down the adoption of new imaging technologies.
- High Cost of Imaging Equipment: The substantial investment required for advanced medical imaging systems can be a deterrent for healthcare facilities, especially in cost-sensitive markets.
- Cybersecurity Concerns: With increasing digitization, the vulnerability of medical imaging devices to cyberattacks is a major concern, affecting market confidence and growth.
- Technological Complexity and Maintenance: The complexity of emerging imaging technologies demands specialized technical expertise for operation and maintenance, limiting widespread adoption across smaller institutions.
- Market Saturation in Developed Countries: The high penetration of medical imaging systems in developed countries leads to a slower growth rate, as replacement cycles are longer and incremental innovations are often not sufficient to trigger new purchases.
MODALITY (X-Ray Systems, CT Scanners, MRI Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems, Fluoroscopy Systems, Others), TECHNOLOGY (Digital Imaging, Analog Imaging, Portable Imaging, Tomosynthesis, Positron Emission Tomography, Single-Photon Emission Computed Tomography), IMAGE TYPE (2D Images, 3D Images, 4D Images), COMPONENT (Imaging Sensors, Detectors, Display Units, Image Processing Units, Contrast Agents), APPLICATION (Oncology, Cardiology, Neurology, Orthopedics, Gastroenterology, Gynecology, Urology, Pulmonology, Others), END-USER (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research And Academic Institutes, Others), And Region
Key Players:
The Medical Imaging Market includes players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Hitachi Medical Corporation, Fujifilm Holdings Corporation, Samsung Medison, Shimadzu Corporation, Hologic, Agfa-Gevaert Group, Carestream Health, Mindray Medical International, Konica Minolta Healthcare, Esaote, Sectra AB, Planmed, Analogic Corporation, United Imaging Healthcare, Optos Plc, and Curium Pharma, among others.
Value Chain Analysis:
The value chain analysis for the Medical Imaging Market encompasses the following stages: Raw Material Procurement, R&D, Product Approval, Large Scale Manufacturing, and Sales and Marketing. Each stage is pivotal to ensuring the seamless delivery of high-quality medical imaging solutions to the market. Below is an in-depth examination of each stage:
- Raw Material Procurement: Identify sources of essential raw materials, such as high-grade silicon, rare earth metals, and other specialized components critical for medical imaging devices. Assess the availability, quality, and sustainability of these materials. Understanding market dynamics, pricing trends, and potential risks associated with sourcing materials is crucial to maintaining a stable supply chain and minimizing production disruptions.
- R&D: Focus on market analysis, trend forecasting, feasibility studies, and conducting experiments to develop innovative imaging technologies. This includes enhancing existing products, improving image resolution, reducing radiation exposure, and integrating AI for advanced diagnostics. Collaboration with academic institutions, research labs, and industry experts is imperative for staying at the forefront of technological advancements.
- Product Approval: Navigate the complex landscape of legal requirements, industry regulations, and certification processes. This involves rigorous testing of products for safety, efficacy, and environmental impact. Securing approvals from regulatory bodies such as the FDA, EMA, and other international health authorities is essential to ensure compliance and facilitate market entry.
- Large Scale Manufacturing: Optimize production processes to enhance efficiency and reduce costs. This includes adopting process engineering, automation technologies, and robust supply chain management practices. Ensuring high standards of quality control and implementing lean manufacturing principles are vital to maintaining product integrity and meeting the demands of a growing market.
- Sales and Marketing: Understand customer needs, market trends, and the competitive landscape to effectively position products in the market. This involves market segmentation, consumer behavior analysis, and the development of compelling branding strategies. Leveraging digital marketing, strategic partnerships, and targeted outreach campaigns can drive product adoption and expand market share.
- Estimates and forecast the overall market size for the total market, across type, application, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
350 Pages
- 1.0: MARKET DEFINITION
- 1.1: MARKET SEGMENTATION
- 1.2: MARKET SEGMENTATION
- 1.3: REGIONAL COVERAGE
- 1.4: KEY COMPANY PROFILES
- 1.5: OTHER KEY PROFILES
- 1.6: DATA SNAPSHOT
- 2.0: SUMMARY
- 2.1: SUMMARY
- 2.2: KEY OPINION LEADERS
- 2.3: KEY HIGHLIGHTS BY MODALITY
- 2.4: KEY HIGHLIGHTS BY TECHNOLOGY
- 2.5: KEY HIGHLIGHTS BY IMAGE TYPE
- 2.6: KEY HIGHLIGHTS BY COMPONENT
- 2.7: KEY HIGHLIGHTS BY APPLICATION
- 2.8: KEY HIGHLIGHTS BY END-USER
- 2.9: KEY HIGHLIGHTS BY REGION
- 2.10: KEY HIGHLIGHTS BY NORTH AMERICA
- 2.11: KEY HIGHLIGHTS BY LATIN AMERICA
- 2.12: KEY HIGHLIGHTS BY EUROPE
- 2.13: KEY HIGHLIGHTS BY ASIA-PACIFIC
- 2.14: KEY HIGHLIGHTS BY MIDDLE EAST AFRICA
- 3.0: MARKET ATTRACTIVENESS ANALYSIS BY MODALITY
- 3.1: MARKET ATTRACTIVENESS ANALYSIS BY TECHNOLOGY
- 3.2: MARKET ATTRACTIVENESS ANALYSIS BY IMAGE TYPE
- 3.3: MARKET ATTRACTIVENESS ANALYSIS BY COMPONENT
- 3.4: MARKET ATTRACTIVENESS ANALYSIS BY APPLICATION
- 3.5: MARKET ATTRACTIVENESS ANALYSIS BY END-USER
- 3.6: MARKET ATTRACTIVENESS ANALYSIS BY REGION
- 3.7: MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
- 4.0: MARKET TRENDS
- 4.1: MARKET DRIVERS
- 4.2: MARKET OPPORTUNITIES
- 4.3: MARKET RESTRAINTS
- 4.4: MARKET THREATS
- 4.5: IMPACT ANALYSIS
- 5.0: PORTERS FIVE FORCES
- 5.1: ANSOFF MATRIX
- 5.2: PESTLE ANALYSIS
- 5.3: VALUE CHAIN ANALYSIS
- 6.0: IMPACT OF COVID-19 ON MARKET
- 7.0: IMPACT OF RUSSIA-UKRAINE WAR
- 8.0: PARENT MARKET ANALYSIS
- 8.1: REGULATORY LANDSCAPE
- 8.2: PRICING ANALYSIS
- 8.3: DEMAND SUPPLY ANALYSIS
- 8.4: DEMAND SUPPLY ANALYSIS
- 8.5: CONSUMER BUYING INTEREST
- 8.6: CONSUMER BUYING INTEREST
- 8.7: SUPPLY CHAIN ANALYSIS
- 8.8: COMPETITION PRODUCT ANALYSIS BY MANUFACTURER
- 8.9: TECHNOLOGICAL ADVANCEMENTS
- 8.10: RECENT DEVELOPMENTS
- 8.11: CASE STUDIES
- 9.0: MARKET SIZE AND FORECAST – BY VALUE (US$ MILLION)
- 9.1: MARKET SIZE AND FORECAST – BY VOLUME (UNITS)
- 10.0: MODALITY OVERVIEW
- 10.1: MARKET SIZE AND FORECAST – BY MODALITY
- 10.2: X-RAY SYSTEMS OVERVIEW
- 10.3: X-RAY SYSTEMS BY REGION
- 10.4: X-RAY SYSTEMS BY COUNTRY
- 10.5: CT SCANNERS OVERVIEW
- 10.6: CT SCANNERS BY REGION
- 10.7: CT SCANNERS BY COUNTRY
- 10.8: MRI SYSTEMS OVERVIEW
- 10.9: MRI SYSTEMS BY REGION
- 10.10: MRI SYSTEMS BY COUNTRY
- 10.11: ULTRASOUND SYSTEMS OVERVIEW
- 10.12: ULTRASOUND SYSTEMS BY REGION
- 10.13: ULTRASOUND SYSTEMS BY COUNTRY
- 10.14: NUCLEAR IMAGING SYSTEMS OVERVIEW
- 10.15: NUCLEAR IMAGING SYSTEMS BY REGION
- 10.16: NUCLEAR IMAGING SYSTEMS BY COUNTRY
- 10.17: MAMMOGRAPHY SYSTEMS OVERVIEW
- 10.18: MAMMOGRAPHY SYSTEMS BY REGION
- 10.19: MAMMOGRAPHY SYSTEMS BY COUNTRY
- 10.20: FLUOROSCOPY SYSTEMS OVERVIEW
- 10.21: FLUOROSCOPY SYSTEMS BY REGION
- 10.22: FLUOROSCOPY SYSTEMS BY COUNTRY
- 10.23: OTHERS OVERVIEW
- 10.24: OTHERS BY REGION
- 10.25: OTHERS BY COUNTRY
- 11.0: TECHNOLOGY OVERVIEW
- 11.1: MARKET SIZE AND FORECAST – BY TECHNOLOGY
- 11.2: DIGITAL IMAGING OVERVIEW
- 11.3: DIGITAL IMAGING BY REGION
- 11.4: DIGITAL IMAGING BY COUNTRY
- 11.5: ANALOG IMAGING OVERVIEW
- 11.6: ANALOG IMAGING BY REGION
- 11.7: ANALOG IMAGING BY COUNTRY
- 11.8: PORTABLE IMAGING OVERVIEW
- 11.9: PORTABLE IMAGING BY REGION
- 11.10: PORTABLE IMAGING BY COUNTRY
- 11.11: TOMOSYNTHESIS OVERVIEW
- 11.12: TOMOSYNTHESIS BY REGION
- 11.13: TOMOSYNTHESIS BY COUNTRY
- 11.14: POSITRON EMISSION TOMOGRAPHY OVERVIEW
- 11.15: POSITRON EMISSION TOMOGRAPHY BY REGION
- 11.16: POSITRON EMISSION TOMOGRAPHY BY COUNTRY
- 11.17: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY OVERVIEW
- 11.18: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY BY REGION
- 11.19: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY BY COUNTRY
- 12.0: IMAGE TYPE OVERVIEW
- 12.1: MARKET SIZE AND FORECAST – BY IMAGE TYPE
- 12.2: 2D IMAGES OVERVIEW
- 12.3: 2D IMAGES BY REGION
- 12.4: 2D IMAGES BY COUNTRY
- 12.5: 3D IMAGES OVERVIEW
- 12.6: 3D IMAGES BY REGION
- 12.7: 3D IMAGES BY COUNTRY
- 12.8: 4D IMAGES OVERVIEW
- 12.9: 4D IMAGES BY REGION
- 12.10: 4D IMAGES BY COUNTRY
- 13.0: COMPONENT OVERVIEW
- 13.1: MARKET SIZE AND FORECAST – BY COMPONENT
- 13.2: IMAGING SENSORS OVERVIEW
- 13.3: IMAGING SENSORS BY REGION
- 13.4: IMAGING SENSORS BY COUNTRY
- 13.5: DETECTORS OVERVIEW
- 13.6: DETECTORS BY REGION
- 13.7: DETECTORS BY COUNTRY
- 13.8: DISPLAY UNITS OVERVIEW
- 13.9: DISPLAY UNITS BY REGION
- 13.10: DISPLAY UNITS BY COUNTRY
- 13.11: IMAGE PROCESSING UNITS OVERVIEW
- 13.12: IMAGE PROCESSING UNITS BY REGION
- 13.13: IMAGE PROCESSING UNITS BY COUNTRY
- 13.14: CONTRAST AGENTS OVERVIEW
- 13.15: CONTRAST AGENTS BY REGION
- 13.16: CONTRAST AGENTS BY COUNTRY
- 14.0: APPLICATION OVERVIEW
- 14.1: MARKET SIZE AND FORECAST – BY APPLICATION
- 14.2: ONCOLOGY OVERVIEW
- 14.3: ONCOLOGY BY REGION
- 14.4: ONCOLOGY BY COUNTRY
- 14.5: CARDIOLOGY OVERVIEW
- 14.6: CARDIOLOGY BY REGION
- 14.7: CARDIOLOGY BY COUNTRY
- 14.8: NEUROLOGY OVERVIEW
- 14.9: NEUROLOGY BY REGION
- 14.10: NEUROLOGY BY COUNTRY
- 14.11: ORTHOPEDICS OVERVIEW
- 14.12: ORTHOPEDICS BY REGION
- 14.13: ORTHOPEDICS BY COUNTRY
- 14.14: GASTROENTEROLOGY OVERVIEW
- 14.15: GASTROENTEROLOGY BY REGION
- 14.16: GASTROENTEROLOGY BY COUNTRY
- 14.17: GYNECOLOGY OVERVIEW
- 14.18: GYNECOLOGY BY REGION
- 14.19: GYNECOLOGY BY COUNTRY
- 14.20: UROLOGY OVERVIEW
- 14.21: UROLOGY BY REGION
- 14.22: UROLOGY BY COUNTRY
- 14.23: PULMONOLOGY OVERVIEW
- 14.24: PULMONOLOGY BY REGION
- 14.25: PULMONOLOGY BY COUNTRY
- 14.26: OTHERS OVERVIEW
- 14.27: OTHERS BY REGION
- 14.28: OTHERS BY COUNTRY
- 15.0: END-USER OVERVIEW
- 15.1: MARKET SIZE AND FORECAST – BY END-USER
- 15.2: HOSPITALS OVERVIEW
- 15.3: HOSPITALS BY REGION
- 15.4: HOSPITALS BY COUNTRY
- 15.5: DIAGNOSTIC IMAGING CENTERS OVERVIEW
- 15.6: DIAGNOSTIC IMAGING CENTERS BY REGION
- 15.7: DIAGNOSTIC IMAGING CENTERS BY COUNTRY
- 15.8: AMBULATORY SURGICAL CENTERS OVERVIEW
- 15.9: AMBULATORY SURGICAL CENTERS BY REGION
- 15.10: AMBULATORY SURGICAL CENTERS BY COUNTRY
- 15.11: RESEARCH AND ACADEMIC INSTITUTES OVERVIEW
- 15.12: RESEARCH AND ACADEMIC INSTITUTES BY REGION
- 15.13: RESEARCH AND ACADEMIC INSTITUTES BY COUNTRY
- 15.14: OTHERS OVERVIEW
- 15.15: OTHERS BY REGION
- 15.16: OTHERS BY COUNTRY
- 16.0: REGION OVERVIEW
- 16.1: MARKET SIZE AND FORECAST - BY REGION
- 16.2: NORTH AMERICA OVERVIEW
- 16.3: NORTH AMERICA BY COUNTRY
- 16.4: UNITED STATES OVERVIEW
- 16.5: UNITED STATES OVERVIEW
- 16.6: UNITED STATES OVERVIEW
- 16.7: UNITED STATES OVERVIEW
- 16.8: UNITED STATES OVERVIEW
- 16.9: UNITED STATES OVERVIEW
- 16.10: UNITED STATES OVERVIEW
- 16.11: LOCAL MARKET ANALYSIS - UNITED STATES
- 16.12: COMPETITIVE ANALYSIS - UNITED STATES
- 16.13: CANADA OVERVIEW
- 16.14: CANADA OVERVIEW
- 16.15: CANADA OVERVIEW
- 16.16: CANADA OVERVIEW
- 16.17: CANADA OVERVIEW
- 16.18: CANADA OVERVIEW
- 16.19: CANADA OVERVIEW
- 16.20: LOCAL MARKET ANALYSIS - CANADA
- 16.21: COMPETITIVE ANALYSIS - CANADA
- 16.22: LATIN AMERICA OVERVIEW
- 16.23: LATIN AMERICA BY COUNTRY
- 16.24: MEXICO OVERVIEW
- 16.25: MEXICO OVERVIEW
- 16.26: MEXICO OVERVIEW
- 16.27: MEXICO OVERVIEW
- 16.28: MEXICO OVERVIEW
- 16.29: MEXICO OVERVIEW
- 16.30: MEXICO OVERVIEW
- 16.31: LOCAL MARKET ANALYSIS - MEXICO
- 16.32: COMPETITIVE ANALYSIS - MEXICO
- 16.33: BRAZIL OVERVIEW
- 16.34: BRAZIL OVERVIEW
- 16.35: BRAZIL OVERVIEW
- 16.36: BRAZIL OVERVIEW
- 16.37: BRAZIL OVERVIEW
- 16.38: BRAZIL OVERVIEW
- 16.39: BRAZIL OVERVIEW
- 16.40: LOCAL MARKET ANALYSIS - BRAZIL
- 16.41: COMPETITIVE ANALYSIS - BRAZIL
- 16.42: ARGENTINA OVERVIEW
- 16.43: ARGENTINA OVERVIEW
- 16.44: ARGENTINA OVERVIEW
- 16.45: ARGENTINA OVERVIEW
- 16.46: ARGENTINA OVERVIEW
- 16.47: ARGENTINA OVERVIEW
- 16.48: ARGENTINA OVERVIEW
- 16.49: LOCAL MARKET ANALYSIS - ARGENTINA
- 16.50: COMPETITIVE ANALYSIS - ARGENTINA
- 16.51: REST OF LATAM OVERVIEW
- 16.52: REST OF LATAM OVERVIEW
- 16.53: REST OF LATAM OVERVIEW
- 16.54: REST OF LATAM OVERVIEW
- 16.55: REST OF LATAM OVERVIEW
- 16.56: REST OF LATAM OVERVIEW
- 16.57: REST OF LATAM OVERVIEW
- 16.58: LOCAL MARKET ANALYSIS - REST OF LATAM
- 16.59: COMPETITIVE ANALYSIS - REST OF LATAM
- 16.60: EUROPE OVERVIEW
- 16.61: EUROPE BY COUNTRY
- 16.62: GERMANY OVERVIEW
- 16.63: GERMANY OVERVIEW
- 16.64: GERMANY OVERVIEW
- 16.65: GERMANY OVERVIEW
- 16.66: GERMANY OVERVIEW
- 16.67: GERMANY OVERVIEW
- 16.68: GERMANY OVERVIEW
- 16.69: LOCAL MARKET ANALYSIS - GERMANY
- 16.70: COMPETITIVE ANALYSIS - GERMANY
- 16.71: FRANCE OVERVIEW
- 16.72: FRANCE OVERVIEW
- 16.73: FRANCE OVERVIEW
- 16.74: FRANCE OVERVIEW
- 16.75: FRANCE OVERVIEW
- 16.76: FRANCE OVERVIEW
- 16.77: FRANCE OVERVIEW
- 16.78: LOCAL MARKET ANALYSIS - FRANCE
- 16.79: COMPETITIVE ANALYSIS - FRANCE
- 16.80: UNITED KINGDOM OVERVIEW
- 16.81: UNITED KINGDOM OVERVIEW
- 16.82: UNITED KINGDOM OVERVIEW
- 16.83: UNITED KINGDOM OVERVIEW
- 16.84: UNITED KINGDOM OVERVIEW
- 16.85: UNITED KINGDOM OVERVIEW
- 16.86: UNITED KINGDOM OVERVIEW
- 16.87: LOCAL MARKET ANALYSIS - UNITED KINGDOM
- 16.88: COMPETITIVE ANALYSIS - UNITED KINGDOM
- 16.89: RUSSIA OVERVIEW
- 16.90: RUSSIA OVERVIEW
- 16.91: RUSSIA OVERVIEW
- 16.92: RUSSIA OVERVIEW
- 16.93: RUSSIA OVERVIEW
- 16.94: RUSSIA OVERVIEW
- 16.95: RUSSIA OVERVIEW
- 16.96: LOCAL MARKET ANALYSIS - RUSSIA
- 16.97: COMPETITIVE ANALYSIS - RUSSIA
- 16.98: SPAIN OVERVIEW
- 16.99: SPAIN OVERVIEW
- 16.100: SPAIN OVERVIEW
- 16.101: SPAIN OVERVIEW
- 16.102: SPAIN OVERVIEW
- 16.103: SPAIN OVERVIEW
- 16.104: SPAIN OVERVIEW
- 16.105: LOCAL MARKET ANALYSIS - SPAIN
- 16.106: COMPETITIVE ANALYSIS - SPAIN
- 16.107: ITALY OVERVIEW
- 16.108: ITALY OVERVIEW
- 16.109: ITALY OVERVIEW
- 16.110: ITALY OVERVIEW
- 16.111: ITALY OVERVIEW
- 16.112: ITALY OVERVIEW
- 16.113: ITALY OVERVIEW
- 16.114: LOCAL MARKET ANALYSIS - ITALY
- 16.115: COMPETITIVE ANALYSIS - ITALY
- 16.116: NETHERLANDS OVERVIEW
- 16.117: NETHERLANDS OVERVIEW
- 16.118: NETHERLANDS OVERVIEW
- 16.119: NETHERLANDS OVERVIEW
- 16.120: NETHERLANDS OVERVIEW
- 16.121: NETHERLANDS OVERVIEW
- 16.122: NETHERLANDS OVERVIEW
- 16.123: LOCAL MARKET ANALYSIS - NETHERLANDS
- 16.124: COMPETITIVE ANALYSIS - NETHERLANDS
- 16.125: ISRAEL OVERVIEW
- 16.126: ISRAEL OVERVIEW
- 16.127: ISRAEL OVERVIEW
- 16.128: ISRAEL OVERVIEW
- 16.129: ISRAEL OVERVIEW
- 16.130: ISRAEL OVERVIEW
- 16.131: ISRAEL OVERVIEW
- 16.132: LOCAL MARKET ANALYSIS - ISRAEL
- 16.133: COMPETITIVE ANALYSIS - ISRAEL
- 16.134: TURKEY OVERVIEW
- 16.135: TURKEY OVERVIEW
- 16.136: TURKEY OVERVIEW
- 16.137: TURKEY OVERVIEW
- 16.138: TURKEY OVERVIEW
- 16.139: TURKEY OVERVIEW
- 16.140: TURKEY OVERVIEW
- 16.141: LOCAL MARKET ANALYSIS - TURKEY
- 16.142: COMPETITIVE ANALYSIS - TURKEY
- 16.143: REST OF EUROPE OVERVIEW
- 16.144: REST OF EUROPE OVERVIEW
- 16.145: REST OF EUROPE OVERVIEW
- 16.146: REST OF EUROPE OVERVIEW
- 16.147: REST OF EUROPE OVERVIEW
- 16.148: REST OF EUROPE OVERVIEW
- 16.149: REST OF EUROPE OVERVIEW
- 16.150: LOCAL MARKET ANALYSIS - REST OF EUROPE
- 16.151: COMPETITIVE ANALYSIS - REST OF EUROPE
- 16.152: ASIA-PACIFIC OVERVIEW
- 16.153: ASIA-PACIFIC BY COUNTRY
- 16.154: CHINA OVERVIEW
- 16.155: CHINA OVERVIEW
- 16.156: CHINA OVERVIEW
- 16.157: CHINA OVERVIEW
- 16.158: CHINA OVERVIEW
- 16.159: CHINA OVERVIEW
- 16.160: CHINA OVERVIEW
- 16.161: LOCAL MARKET ANALYSIS - CHINA
- 16.162: COMPETITIVE ANALYSIS - CHINA
- 16.163: INDIA OVERVIEW
- 16.164: INDIA OVERVIEW
- 16.165: INDIA OVERVIEW
- 16.166: INDIA OVERVIEW
- 16.167: INDIA OVERVIEW
- 16.168: INDIA OVERVIEW
- 16.169: INDIA OVERVIEW
- 16.170: LOCAL MARKET ANALYSIS - INDIA
- 16.171: COMPETITIVE ANALYSIS - INDIA
- 16.172: JAPAN OVERVIEW
- 16.173: JAPAN OVERVIEW
- 16.174: JAPAN OVERVIEW
- 16.175: JAPAN OVERVIEW
- 16.176: JAPAN OVERVIEW
- 16.177: JAPAN OVERVIEW
- 16.178: JAPAN OVERVIEW
- 16.179: LOCAL MARKET ANALYSIS - JAPAN
- 16.180: COMPETITIVE ANALYSIS - JAPAN
- 16.181: AUSTRALIA OVERVIEW
- 16.182: AUSTRALIA OVERVIEW
- 16.183: AUSTRALIA OVERVIEW
- 16.184: AUSTRALIA OVERVIEW
- 16.185: AUSTRALIA OVERVIEW
- 16.186: AUSTRALIA OVERVIEW
- 16.187: AUSTRALIA OVERVIEW
- 16.188: LOCAL MARKET ANALYSIS - AUSTRALIA
- 16.189: COMPETITIVE ANALYSIS - AUSTRALIA
- 16.190: INDONESIA OVERVIEW
- 16.191: INDONESIA OVERVIEW
- 16.192: INDONESIA OVERVIEW
- 16.193: INDONESIA OVERVIEW
- 16.194: INDONESIA OVERVIEW
- 16.195: INDONESIA OVERVIEW
- 16.196: INDONESIA OVERVIEW
- 16.197: LOCAL MARKET ANALYSIS - INDONESIA
- 16.198: COMPETITIVE ANALYSIS - INDONESIA
- 16.199: MALAYSIA OVERVIEW
- 16.200: MALAYSIA OVERVIEW
- 16.201: MALAYSIA OVERVIEW
- 16.202: MALAYSIA OVERVIEW
- 16.203: MALAYSIA OVERVIEW
- 16.204: MALAYSIA OVERVIEW
- 16.205: MALAYSIA OVERVIEW
- 16.206: LOCAL MARKET ANALYSIS - MALAYSIA
- 16.207: COMPETITIVE ANALYSIS - MALAYSIA
- 16.208: REST OF APAC OVERVIEW
- 16.209: REST OF APAC OVERVIEW
- 16.210: REST OF APAC OVERVIEW
- 16.211: REST OF APAC OVERVIEW
- 16.212: REST OF APAC OVERVIEW
- 16.213: REST OF APAC OVERVIEW
- 16.214: REST OF APAC OVERVIEW
- 16.215: LOCAL MARKET ANALYSIS - REST OF APAC
- 16.216: COMPETITIVE ANALYSIS - REST OF APAC
- 16.217: MIDDLE EAST AFRICA OVERVIEW
- 16.218: MIDDLE EAST AFRICA BY COUNTRY
- 16.219: SAUDI ARABIA OVERVIEW
- 16.220: SAUDI ARABIA OVERVIEW
- 16.221: SAUDI ARABIA OVERVIEW
- 16.222: SAUDI ARABIA OVERVIEW
- 16.223: SAUDI ARABIA OVERVIEW
- 16.224: SAUDI ARABIA OVERVIEW
- 16.225: SAUDI ARABIA OVERVIEW
- 16.226: LOCAL MARKET ANALYSIS - SAUDI ARABIA
- 16.227: COMPETITIVE ANALYSIS - SAUDI ARABIA
- 16.228: UAE OVERVIEW
- 16.229: UAE OVERVIEW
- 16.230: UAE OVERVIEW
- 16.231: UAE OVERVIEW
- 16.232: UAE OVERVIEW
- 16.233: UAE OVERVIEW
- 16.234: UAE OVERVIEW
- 16.235: LOCAL MARKET ANALYSIS - UAE
- 16.236: COMPETITIVE ANALYSIS - UAE
- 16.237: SOUTH AFRICA OVERVIEW
- 16.238: SOUTH AFRICA OVERVIEW
- 16.239: SOUTH AFRICA OVERVIEW
- 16.240: SOUTH AFRICA OVERVIEW
- 16.241: SOUTH AFRICA OVERVIEW
- 16.242: SOUTH AFRICA OVERVIEW
- 16.243: SOUTH AFRICA OVERVIEW
- 16.244: LOCAL MARKET ANALYSIS - SOUTH AFRICA
- 16.245: COMPETITIVE ANALYSIS - SOUTH AFRICA
- 16.246: IRAN OVERVIEW
- 16.247: IRAN OVERVIEW
- 16.248: IRAN OVERVIEW
- 16.249: IRAN OVERVIEW
- 16.250: IRAN OVERVIEW
- 16.251: IRAN OVERVIEW
- 16.252: IRAN OVERVIEW
- 16.253: LOCAL MARKET ANALYSIS - IRAN
- 16.254: COMPETITIVE ANALYSIS - IRAN
- 16.255: QATAR OVERVIEW
- 16.256: QATAR OVERVIEW
- 16.257: QATAR OVERVIEW
- 16.258: QATAR OVERVIEW
- 16.259: QATAR OVERVIEW
- 16.260: QATAR OVERVIEW
- 16.261: QATAR OVERVIEW
- 16.262: LOCAL MARKET ANALYSIS - QATAR
- 16.263: COMPETITIVE ANALYSIS - QATAR
- 16.264: REST OF MEA OVERVIEW
- 16.265: REST OF MEA OVERVIEW
- 16.266: REST OF MEA OVERVIEW
- 16.267: REST OF MEA OVERVIEW
- 16.268: REST OF MEA OVERVIEW
- 16.269: REST OF MEA OVERVIEW
- 16.270: REST OF MEA OVERVIEW
- 16.271: LOCAL MARKET ANALYSIS - REST OF MEA
- 16.272: COMPETITIVE ANALYSIS - REST OF MEA
- 17.0: COMPETITION OVERVIEW
- 17.1: MARKET SHARE ANALYSIS
- 17.2: MARKET REVENUE BY KEY COMPANIES
- 17.3: MARKET POSITIONING
- 17.4: VENDORS BENCHMARKING
- 17.5: STRATEGY BENCHMARKING
- 17.6: STRATEGY BENCHMARKING
- 18.0: Siemens Healthineers
- 18.1: Siemens Healthineers
- 18.2: Siemens Healthineers
- 18.3: Siemens Healthineers
- 18.4: Siemens Healthineers
- 18.5: GE Healthcare
- 18.6: GE Healthcare
- 18.7: GE Healthcare
- 18.8: GE Healthcare
- 18.9: GE Healthcare
- 18.10: Philips Healthcare
- 18.11: Philips Healthcare
- 18.12: Philips Healthcare
- 18.13: Philips Healthcare
- 18.14: Philips Healthcare
- 18.15: Canon Medical Systems
- 18.16: Canon Medical Systems
- 18.17: Canon Medical Systems
- 18.18: Canon Medical Systems
- 18.19: Canon Medical Systems
- 18.20: Hitachi Medical Corporation
- 18.21: Hitachi Medical Corporation
- 18.22: Hitachi Medical Corporation
- 18.23: Hitachi Medical Corporation
- 18.24: Hitachi Medical Corporation
- 18.25: Fujifilm Holdings Corporation
- 18.26: Fujifilm Holdings Corporation
- 18.27: Fujifilm Holdings Corporation
- 18.28: Fujifilm Holdings Corporation
- 18.29: Fujifilm Holdings Corporation
- 18.30: Samsung Medison
- 18.31: Samsung Medison
- 18.32: Samsung Medison
- 18.33: Samsung Medison
- 18.34: Samsung Medison
- 18.35: Shimadzu Corporation
- 18.36: Shimadzu Corporation
- 18.37: Shimadzu Corporation
- 18.38: Shimadzu Corporation
- 18.39: Shimadzu Corporation
- 18.40: Hologic
- 18.41: Hologic
- 18.42: Hologic
- 18.43: Hologic
- 18.44: Hologic
- 18.45: Agfa-Gevaert Group
- 18.46: Agfa-Gevaert Group
- 18.47: Agfa-Gevaert Group
- 18.48: Agfa-Gevaert Group
- 18.49: Agfa-Gevaert Group
- 18.50: Carestream Health
- 18.51: Carestream Health
- 18.52: Carestream Health
- 18.53: Carestream Health
- 18.54: Carestream Health
- 18.55: Mindray Medical International
- 18.56: Mindray Medical International
- 18.57: Mindray Medical International
- 18.58: Mindray Medical International
- 18.59: Mindray Medical International
- 18.60: Konica Minolta Healthcare
- 18.61: Konica Minolta Healthcare
- 18.62: Konica Minolta Healthcare
- 18.63: Konica Minolta Healthcare
- 18.64: Konica Minolta Healthcare
- 18.65: Esaote
- 18.66: Esaote
- 18.67: Esaote
- 18.68: Esaote
- 18.69: Esaote
- 18.70: Sectra AB
- 18.71: Sectra AB
- 18.72: Sectra AB
- 18.73: Sectra AB
- 18.74: Sectra AB
- 18.75: Planmed
- 18.76: Planmed
- 18.77: Planmed
- 18.78: Planmed
- 18.79: Planmed
- 18.80: Analogic Corporation
- 18.81: Analogic Corporation
- 18.82: Analogic Corporation
- 18.83: Analogic Corporation
- 18.84: Analogic Corporation
- 18.85: United Imaging Healthcare
- 18.86: United Imaging Healthcare
- 18.87: United Imaging Healthcare
- 18.88: United Imaging Healthcare
- 18.89: United Imaging Healthcare
- 18.90: Optos Plc
- 18.91: Optos Plc
- 18.92: Optos Plc
- 18.93: Optos Plc
- 18.94: Optos Plc
- 18.95: Curium Pharma
- 18.96: Curium Pharma
- 18.97: Curium Pharma
- 18.98: Curium Pharma
- 18.99: Curium Pharma
- 580})
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.